You are here

Novartis and its Foundation Establish $5M COVID-19 Community Fund

Novartis and its Foundation Establish $5M COVID-19 Community Fund

Friday, April 3, 2020

In response to the coronavirus outbreak currently afflicting the United States, East Hanover-based Novartis and its foundation arm announced on Friday they have established a U.S. COVID-19 Community Response Fund.

The fund will provide cash and in-kind donations totaling $5 million for immediate response to the pandemic.

“COVID-19 has profoundly impacted the lives of Americans in many unprecedented ways. As a leading medicines company, we understand the public health implications of this pandemic and must do our part to support organizations that are in the best position to provide services to people in need,” Tom Kendris, U.S. country president, Novartis Corp. and chairman, board of trustees, Novartis US Foundation, said. “This latest commitment is just one of many Novartis has made to help fight COVID-19 globally. From donations of hydroxychloroquine, monetary funds and equipment donations, to R&D programs and collaborations, we are humbled and pleased to offer financial support as well as scientific expertise.”